Literature DB >> 759055

Polymorphism of apolipoprotein E. III. Effect of a single polymorphic gene locus on plasma lipid levels in man.

G Utermann, N Pruin, A Steinmetz.   

Abstract

The two autosomal codominant alleles of the Apo E-N/D polymorphism, Apo En and Apo Ed, have a considerable influence on plasma lipid levels and distribution in man. Serum cholesterol levels are highest in phenotype Apo E-N, intermediate in phenotype Apo E-ND, and low in phenotype Apo E-D. Contrary VLDL-cholesterol is highest in phenotype Apo E-D, intermediate in heterozygotes, and lowest in phenotype Apo E-N. Serum-triglyceride, VLDL-triglyceride and the ratio of VLDL-cholesterol/serum-triglyceride are also intermediate in phenotype Apo E-ND between the two opposite homozygous groups. 10% of heterozygous Apo E-ND subjects exhibited a beta-VLDL subfraction compared to 0.8% in phenotype Apo E-N and 100% in Apo E-D. Hence the three phenotypic groups exhibit metabolic differences in vivo, and the gene Apo Ed has a mild dyslipoproteinemic effect even in a single dose. The Apo E-N/D polymorphism may therefore be a major influence on the occurrence of arteriosclerotic vascular disease in man.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 759055

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  36 in total

Review 1.  Genetic basis of lipoprotein disorders.

Authors:  J L Breslow
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

2.  Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism.

Authors:  E Boerwinkle; G Utermann
Journal:  Am J Hum Genet       Date:  1988-01       Impact factor: 11.025

3.  Apolipoprotein E polymorphism and atherosclerosis: insight from a study in octogenarians.

Authors:  J Davignon; D Bouthillier; A C Nestruck; C F Sing
Journal:  Trans Am Clin Climatol Assoc       Date:  1988

4.  Apolipoprotein E polymorphism in The Netherlands and its effect on plasma lipid and apolipoprotein levels.

Authors:  M Smit; P de Knijff; M Rosseneu; J Bury; E Klasen; R Frants; L Havekes
Journal:  Hum Genet       Date:  1988-11       Impact factor: 4.132

5.  [Apolipoproteinopathies].

Authors:  G Assmann
Journal:  Klin Wochenschr       Date:  1983-02-15

6.  A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1.

Authors:  K H Weisgraber; S C Rall; T L Innerarity; R W Mahley; T Kuusi; C Ehnholm
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

7.  Radioimmunoassay of human arginine-rich apolipoprotein, apoprotein E. Concentration in blood plasma and lipoproteins as affected by apoprotein E-3 deficiency.

Authors:  R J Havel; L Kotite; J L Vigne; J P Kane; P Tun; N Phillips; G C Chen
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

8.  Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E.

Authors:  M S Weintraub; S Eisenberg; J L Breslow
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

9.  Apolipoprotein E phenotypes in patients with myocardial infarction.

Authors:  G Utermann; A Hardewig; F Zimmer
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

10.  A common restriction fragment length polymorphism of the human apolipoprotein E gene and its relationship to type III hyperlipidaemia.

Authors:  E C Klasen; P J Talmud; L Havekes; E de Wit; E van der Kooij-Meijs; M Smit; G Hansson; S E Humphries
Journal:  Hum Genet       Date:  1987-03       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.